miRNA Preferred Medicine Building Data for Breast Cancer MicroRNA Screening Test Premium The company is working with three institutions to recruit about 1,200 case-control participants for its validation study, with plans to launch an LDT next year. Lithuanian Team Developing Droplet-Based Single-Cell Small RNA Sequencing Approach Premium The European Union has backed the project, called Droplet-Small-Seq, with a €146,000 Horizon 2020 research grant. COVID-19 Severity Linked to mRNA, lncRNA Signature in Blood The researchers said that more research into these biomarkers could help with patient stratification and therapy selection. Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test. Summit Biolabs Commercializing Tests for Head and Neck Cancer Recurrence, COVID-19 Premium The firm's platform, dubbed HNKlear, uses methylation-specific PCR to detect microRNA biomarkers in a patient's blood sample following frontline cancer treatment. Sep 15, 2020 Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion Jul 9, 2020 Integrated Proteomic Papers Define Lung Cancer Features Across Populations, Smoking Histories May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers Apr 6, 2020 MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval Premium Mar 5, 2020 Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer Dec 18, 2019 ALS Genomic Analysis Highlights Potential MicroRNA Contributor Nov 21, 2019 DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research Oct 10, 2019 FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 19, 2019 Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia Premium Sep 16, 2019 Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA Aug 29, 2019 Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 30, 2019 Pan-Cancer Study Uncovers TP53 Mutation Consequences, Related Prognostic Expression Signature Jul 16, 2019 Arcis Licenses Sample Prep Technology to microRNA Diagnostics Firm Mirnax Biosens Jul 12, 2019 Avalon GloboCare Using Exosome Isolation Platform to Pursue Oral Cancer Dx, Rx Applications Premium Jul 2, 2019 Noninvasive Endometriosis Test Developer DotLab Secures $10M in Series A Funding Jun 17, 2019 Q BioMed Using MicroRNA Biomarkers to Guide Therapy Development in Subset of Autism Patients Premium Apr 25, 2019 Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis Mar 28, 2019 MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer Premium Load More Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.